What is dabigatran etexilate mesylate 150 mg used for?
Dabigatran etexilate mesylate is an oral anticoagulant (a blood thinner). The 150 mg capsule strength is used to reduce the risk of stroke and systemic embolism in people with nonvalvular atrial fibrillation. It is also used as part of certain treatment strategies to help prevent blood clots, depending on the specific indication ordered by the clinician.
What is the capsule and how is it taken (150 mg)?
The medication comes as a capsule containing dabigatran etexilate (as the mesylate salt). Typical use is twice daily for atrial fibrillation—however, the exact dosing schedule depends on the prescribed regimen and patient factors (especially kidney function). Follow the directions on the prescription and the product labeling.
Is 150 mg safe for people with kidney problems?
Kidney function matters for dabigatran because clearance is largely renal. Patients with reduced kidney function may have higher dabigatran levels and greater bleeding risk, so dosing and suitability for the 150 mg strength depend on lab values and clinical judgment.
How does the 150 mg capsule compare with other dabigatran strengths?
Dabigatran is also available in different capsule strengths. The choice of 75 mg vs 110 mg vs 150 mg (depending on country/labeling) is based on approved indications and safety considerations such as bleeding risk and renal function.
Who should not take dabigatran 150 mg?
People with contraindications to anticoagulation or those at increased bleeding risk may not be appropriate candidates. Common clinical reasons to avoid or adjust anticoagulants include active pathological bleeding, certain recent surgeries/bleeds, and severe renal impairment, among others that clinicians screen for.
How to prevent medication mix-ups with anticoagulants
Because dabigatran is a high-risk medicine when taken incorrectly, confirm:
- the exact product (dabigatran etexilate mesylate),
- the strength (150 mg),
- the dosing frequency (often twice daily for atrial fibrillation, but only as prescribed),
- and whether any dose changes were made due to kidney function.
What should patients do if they miss a dose or start bleeding?
For missed-dose guidance and what to do during bleeding, the correct steps depend on the indication and the timing of the missed dose. If bleeding is severe (for example, uncontrolled bleeding, black/tarry stools, vomiting blood, or signs of stroke), seek urgent medical care. For missed doses, patients should follow the instructions in their medication guide or call their prescriber/pharmacist for the specific timing-based rule.
---
If you tell me what you need—general info, dosing for atrial fibrillation, kidney-related safety, side effects, or whether “150 mg” is the right dose for your situation—I can narrow it to the most relevant guidance.